Free US stock comparative valuation tools and peer analysis to identify mispriced securities and find value opportunities in the market. We help you understand relative value across different metrics and time periods for better investment decisions. Our platform offers peer comparisons, relative valuation, and spread analysis for comprehensive valuation coverage. Find mispriced stocks with our comprehensive valuation tools and expert analysis for smarter investment selection.
Becton Dickinson and Company (BDX), a leading global medical technology firm, is trading at $154.96 as of 2026-04-07, posting a modest 0.23% decline on the day. This analysis focuses on key technical levels, recent market context, and potential trading scenarios for the stock amid current broad market and sector dynamics. With no company-specific earnings updates recently released, price action for BDX has been largely driven by sector flows and technical positioning in recent weeks, making supp
What do forecasts say about BD (BDX) Stock | Price at $154.96, Down 0.23% - Stock Surge Alerts
BDX - Stock Analysis
4199 Comments
1899 Likes
1
Garet
Returning User
2 hours ago
Surely I’m not the only one.
👍 151
Reply
2
Alvester
Regular Reader
5 hours ago
There’s got to be more of us here.
👍 233
Reply
3
Rosanne
Active Reader
1 day ago
That’s some award-winning stuff. 🏆
👍 169
Reply
4
Audrii
Power User
1 day ago
This is the kind of thing I’m always late to.
👍 149
Reply
5
Neely
Senior Contributor
2 days ago
Markets are showing short-term consolidation before the next move.
👍 95
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.